Astellas Announces Launch of Dafclir® Tablets for the Treatment of Infectious Enteritis Caused by Clostridium difficile in Japan
(WorldNews Japan)

18 september 2018 05:40:26

TOKYO, September 18, 2018 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., `Astellas` ) today announced that it has launched Dafclir® Tablets 200 mg (generic name: fidaxomicin, `Dafclir®`) for the treatment of infectious enteritis (including pseudomembranous colitis1) (susceptible strains: fidaxomicin susceptible Clostridium...

6 viewsCategory: General > Asia > Japan

SpaceX says Japanese billionaire Maezawa will be 1st private passenger on rocket trip around the moon
(Japan Today)
FY2018 Second Quarter Consolidated Financial Results is planned to be announced on October 30 (15:00 JST)
(WorldNews Japan)

Astellas Announces Launch of Dafclir® Tablets for the Treatment of Infectious Enteritis Caused by Clostridium difficile in Japan(WorldNews Japan)

18 september 2018 05:40:26

Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice. Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten

Astellas Announces Launch of Dafclir® Tablets for the Treatment of Infectious Enteritis Caused by Clostridium difficile in Japan
(WorldNews Japan)

Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten